c-MET EXPRESSION AS AN INDICATOR OF SURVIVAL OUTCOME IN PATIENTS WITH ORAL TONGUE CARCINOMA
c-MET EXPRESSION AS AN INDICATOR OF SURVIVAL OUTCOME IN PATIENTS WITH ORAL TONGUE CARCINOMA
复制标题
DOI:
10.1002/hed.21383
复制
发表时间:
2010-12-01
影响因子:
2.9
通讯作者:
Choi, Eun Chang
中科院分区:
文献类型:
--
作者:
Kim, Chul-Ho;Koh, Yoon Woo;Choi, Eun Chang
Background. Hepatocyte growth factor (HGF) can promote proliferation, invasion, and angiogenesis in various tumor cells. However, the prognosis according to expression of HGF/c-Met has not been reported in patients with squamous cell carcinoma of the oral tongue (SCOOT).Methods. Tumors from 61 patients with SCOOT were evaluated for the expression of HGF and c-Met by immunohistochemistry. For Western blot, we used fresh normal and cancer tissues from 3 patients with SCOOT.Results. The positive rates of HGF and c-Met immunostaining in SCOOT were 57.3% and 54.1%, respectively. The c-Met staining was significantly correlated with lymph node metastasis (p = .005), tumor classification (p = .004), and recurrence (p = .018). Survival was significantly affected in patients with positive c-Met expression (p = .003). HGF and c-Met were strongly expressed in cancer tissues on Western blot.Conclusion. The c-Met expression may play an important role in the progression and the survival outcome of patients with SCOOT. (C) 2010 Wiley Periodicals, Inc. Head Neck 32: 1655-1664, 2010